May.14 — Aurora Cannabis’ U.S.-listed shares fell sharply after its 3Q net revenue missed the average analyst estimate due to weakness in the recreational segment. CEO Miguel Martin talks about it on “Bloomberg Markets.”
Covid Hurt Marijuana Sales for Aurora, CEO Says
